0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Swine Parvovirus Disease Vaccine Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-30N14925
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Swine Parvovirus Disease Vaccine Market Insights Forecast to 2029
BUY CHAPTERS

Global Swine Parvovirus Disease Vaccine Market Research Report 2024

Code: QYRE-Auto-30N14925
Report
April 2024
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Swine Parvovirus Disease Vaccine Market

The global Swine Parvovirus Disease Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Swine Parvovirus Disease Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Swine Parvovirus Disease Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Swine Parvovirus Disease Vaccine include Merck Animal Health, HIPRA, Zoetis, Ceva, Bioveta, Boehringer Ingelheim, Harbin Pharmaceutical Group, Wuhan Keqian Biology and DHN, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Swine Parvovirus Disease Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Parvovirus Disease Vaccine.

Report Scope

The Swine Parvovirus Disease Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Swine Parvovirus Disease Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Parvovirus Disease Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Swine Parvovirus Disease Vaccine Market Report

Report Metric Details
Report Name Swine Parvovirus Disease Vaccine Market
Segment by Type
  • <107.0 TCID50/mL
  • ≥107.0 TCID50/mL
Segment by Application
  • Sows
  • Boars
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck Animal Health, HIPRA, Zoetis, Ceva, Bioveta, Boehringer Ingelheim, Harbin Pharmaceutical Group, Wuhan Keqian Biology, DHN, China Animal Husbandy Industry, Qilu Animal Health Products Factorys, Shandong HuaHong Biological Engineering, Shanghai Hile Biological, Liaoning Yikang Biological, Jilin Zhengye Biological Product
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Swine Parvovirus Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Swine Parvovirus Disease Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Swine Parvovirus Disease Vaccine Market report?

Ans: The main players in the Swine Parvovirus Disease Vaccine Market are Merck Animal Health, HIPRA, Zoetis, Ceva, Bioveta, Boehringer Ingelheim, Harbin Pharmaceutical Group, Wuhan Keqian Biology, DHN, China Animal Husbandy Industry, Qilu Animal Health Products Factorys, Shandong HuaHong Biological Engineering, Shanghai Hile Biological, Liaoning Yikang Biological, Jilin Zhengye Biological Product

What are the Application segmentation covered in the Swine Parvovirus Disease Vaccine Market report?

Ans: The Applications covered in the Swine Parvovirus Disease Vaccine Market report are Sows, Boars

What are the Type segmentation covered in the Swine Parvovirus Disease Vaccine Market report?

Ans: The Types covered in the Swine Parvovirus Disease Vaccine Market report are <107.0 TCID50/mL, ≥107.0 TCID50/mL

1 Swine Parvovirus Disease Vaccine Market Overview
1.1 Product Overview and Scope of Swine Parvovirus Disease Vaccine
1.2 Swine Parvovirus Disease Vaccine Segment by Type
1.2.1 Global Swine Parvovirus Disease Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 <107.0 TCID50/mL
1.2.3 ≥107.0 TCID50/mL
1.3 Swine Parvovirus Disease Vaccine Segment by Application
1.3.1 Global Swine Parvovirus Disease Vaccine Market Value by Application: (2024-2030)
1.3.2 Sows
1.3.3 Boars
1.4 Global Swine Parvovirus Disease Vaccine Market Size Estimates and Forecasts
1.4.1 Global Swine Parvovirus Disease Vaccine Revenue 2019-2030
1.4.2 Global Swine Parvovirus Disease Vaccine Sales 2019-2030
1.4.3 Global Swine Parvovirus Disease Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Swine Parvovirus Disease Vaccine Market Competition by Manufacturers
2.1 Global Swine Parvovirus Disease Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Swine Parvovirus Disease Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Swine Parvovirus Disease Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Swine Parvovirus Disease Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Swine Parvovirus Disease Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Swine Parvovirus Disease Vaccine, Product Type & Application
2.7 Swine Parvovirus Disease Vaccine Market Competitive Situation and Trends
2.7.1 Swine Parvovirus Disease Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Swine Parvovirus Disease Vaccine Players Market Share by Revenue
2.7.3 Global Swine Parvovirus Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Swine Parvovirus Disease Vaccine Retrospective Market Scenario by Region
3.1 Global Swine Parvovirus Disease Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Swine Parvovirus Disease Vaccine Global Swine Parvovirus Disease Vaccine Sales by Region: 2019-2030
3.2.1 Global Swine Parvovirus Disease Vaccine Sales by Region: 2019-2024
3.2.2 Global Swine Parvovirus Disease Vaccine Sales by Region: 2025-2030
3.3 Global Swine Parvovirus Disease Vaccine Global Swine Parvovirus Disease Vaccine Revenue by Region: 2019-2030
3.3.1 Global Swine Parvovirus Disease Vaccine Revenue by Region: 2019-2024
3.3.2 Global Swine Parvovirus Disease Vaccine Revenue by Region: 2025-2030
3.4 North America Swine Parvovirus Disease Vaccine Market Facts & Figures by Country
3.4.1 North America Swine Parvovirus Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Swine Parvovirus Disease Vaccine Sales by Country (2019-2030)
3.4.3 North America Swine Parvovirus Disease Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Swine Parvovirus Disease Vaccine Market Facts & Figures by Country
3.5.1 Europe Swine Parvovirus Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Swine Parvovirus Disease Vaccine Sales by Country (2019-2030)
3.5.3 Europe Swine Parvovirus Disease Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Swine Parvovirus Disease Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Swine Parvovirus Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Swine Parvovirus Disease Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Swine Parvovirus Disease Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Swine Parvovirus Disease Vaccine Market Facts & Figures by Country
3.7.1 Latin America Swine Parvovirus Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Swine Parvovirus Disease Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Swine Parvovirus Disease Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Swine Parvovirus Disease Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Swine Parvovirus Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Swine Parvovirus Disease Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Swine Parvovirus Disease Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Swine Parvovirus Disease Vaccine Sales by Type (2019-2030)
4.1.1 Global Swine Parvovirus Disease Vaccine Sales by Type (2019-2024)
4.1.2 Global Swine Parvovirus Disease Vaccine Sales by Type (2025-2030)
4.1.3 Global Swine Parvovirus Disease Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Swine Parvovirus Disease Vaccine Revenue by Type (2019-2030)
4.2.1 Global Swine Parvovirus Disease Vaccine Revenue by Type (2019-2024)
4.2.2 Global Swine Parvovirus Disease Vaccine Revenue by Type (2025-2030)
4.2.3 Global Swine Parvovirus Disease Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Swine Parvovirus Disease Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Swine Parvovirus Disease Vaccine Sales by Application (2019-2030)
5.1.1 Global Swine Parvovirus Disease Vaccine Sales by Application (2019-2024)
5.1.2 Global Swine Parvovirus Disease Vaccine Sales by Application (2025-2030)
5.1.3 Global Swine Parvovirus Disease Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Swine Parvovirus Disease Vaccine Revenue by Application (2019-2030)
5.2.1 Global Swine Parvovirus Disease Vaccine Revenue by Application (2019-2024)
5.2.2 Global Swine Parvovirus Disease Vaccine Revenue by Application (2025-2030)
5.2.3 Global Swine Parvovirus Disease Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Swine Parvovirus Disease Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck Animal Health
6.1.1 Merck Animal Health Corporation Information
6.1.2 Merck Animal Health Description and Business Overview
6.1.3 Merck Animal Health Swine Parvovirus Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Animal Health Swine Parvovirus Disease Vaccine Product Portfolio
6.1.5 Merck Animal Health Recent Developments/Updates
6.2 HIPRA
6.2.1 HIPRA Corporation Information
6.2.2 HIPRA Description and Business Overview
6.2.3 HIPRA Swine Parvovirus Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 HIPRA Swine Parvovirus Disease Vaccine Product Portfolio
6.2.5 HIPRA Recent Developments/Updates
6.3 Zoetis
6.3.1 Zoetis Corporation Information
6.3.2 Zoetis Description and Business Overview
6.3.3 Zoetis Swine Parvovirus Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Zoetis Swine Parvovirus Disease Vaccine Product Portfolio
6.3.5 Zoetis Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Corporation Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Swine Parvovirus Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Swine Parvovirus Disease Vaccine Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 Bioveta
6.5.1 Bioveta Corporation Information
6.5.2 Bioveta Description and Business Overview
6.5.3 Bioveta Swine Parvovirus Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bioveta Swine Parvovirus Disease Vaccine Product Portfolio
6.5.5 Bioveta Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Swine Parvovirus Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Boehringer Ingelheim Swine Parvovirus Disease Vaccine Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
6.7 Harbin Pharmaceutical Group
6.6.1 Harbin Pharmaceutical Group Corporation Information
6.6.2 Harbin Pharmaceutical Group Description and Business Overview
6.6.3 Harbin Pharmaceutical Group Swine Parvovirus Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Harbin Pharmaceutical Group Swine Parvovirus Disease Vaccine Product Portfolio
6.7.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.8 Wuhan Keqian Biology
6.8.1 Wuhan Keqian Biology Corporation Information
6.8.2 Wuhan Keqian Biology Description and Business Overview
6.8.3 Wuhan Keqian Biology Swine Parvovirus Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Wuhan Keqian Biology Swine Parvovirus Disease Vaccine Product Portfolio
6.8.5 Wuhan Keqian Biology Recent Developments/Updates
6.9 DHN
6.9.1 DHN Corporation Information
6.9.2 DHN Description and Business Overview
6.9.3 DHN Swine Parvovirus Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 DHN Swine Parvovirus Disease Vaccine Product Portfolio
6.9.5 DHN Recent Developments/Updates
6.10 China Animal Husbandy Industry
6.10.1 China Animal Husbandy Industry Corporation Information
6.10.2 China Animal Husbandy Industry Description and Business Overview
6.10.3 China Animal Husbandy Industry Swine Parvovirus Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 China Animal Husbandy Industry Swine Parvovirus Disease Vaccine Product Portfolio
6.10.5 China Animal Husbandy Industry Recent Developments/Updates
6.11 Qilu Animal Health Products Factorys
6.11.1 Qilu Animal Health Products Factorys Corporation Information
6.11.2 Qilu Animal Health Products Factorys Swine Parvovirus Disease Vaccine Description and Business Overview
6.11.3 Qilu Animal Health Products Factorys Swine Parvovirus Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Qilu Animal Health Products Factorys Swine Parvovirus Disease Vaccine Product Portfolio
6.11.5 Qilu Animal Health Products Factorys Recent Developments/Updates
6.12 Shandong HuaHong Biological Engineering
6.12.1 Shandong HuaHong Biological Engineering Corporation Information
6.12.2 Shandong HuaHong Biological Engineering Swine Parvovirus Disease Vaccine Description and Business Overview
6.12.3 Shandong HuaHong Biological Engineering Swine Parvovirus Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shandong HuaHong Biological Engineering Swine Parvovirus Disease Vaccine Product Portfolio
6.12.5 Shandong HuaHong Biological Engineering Recent Developments/Updates
6.13 Shanghai Hile Biological
6.13.1 Shanghai Hile Biological Corporation Information
6.13.2 Shanghai Hile Biological Swine Parvovirus Disease Vaccine Description and Business Overview
6.13.3 Shanghai Hile Biological Swine Parvovirus Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Shanghai Hile Biological Swine Parvovirus Disease Vaccine Product Portfolio
6.13.5 Shanghai Hile Biological Recent Developments/Updates
6.14 Liaoning Yikang Biological
6.14.1 Liaoning Yikang Biological Corporation Information
6.14.2 Liaoning Yikang Biological Swine Parvovirus Disease Vaccine Description and Business Overview
6.14.3 Liaoning Yikang Biological Swine Parvovirus Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Liaoning Yikang Biological Swine Parvovirus Disease Vaccine Product Portfolio
6.14.5 Liaoning Yikang Biological Recent Developments/Updates
6.15 Jilin Zhengye Biological Product
6.15.1 Jilin Zhengye Biological Product Corporation Information
6.15.2 Jilin Zhengye Biological Product Swine Parvovirus Disease Vaccine Description and Business Overview
6.15.3 Jilin Zhengye Biological Product Swine Parvovirus Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Jilin Zhengye Biological Product Swine Parvovirus Disease Vaccine Product Portfolio
6.15.5 Jilin Zhengye Biological Product Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Swine Parvovirus Disease Vaccine Industry Chain Analysis
7.2 Swine Parvovirus Disease Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Swine Parvovirus Disease Vaccine Production Mode & Process
7.4 Swine Parvovirus Disease Vaccine Sales and Marketing
7.4.1 Swine Parvovirus Disease Vaccine Sales Channels
7.4.2 Swine Parvovirus Disease Vaccine Distributors
7.5 Swine Parvovirus Disease Vaccine Customers
8 Swine Parvovirus Disease Vaccine Market Dynamics
8.1 Swine Parvovirus Disease Vaccine Industry Trends
8.2 Swine Parvovirus Disease Vaccine Market Drivers
8.3 Swine Parvovirus Disease Vaccine Market Challenges
8.4 Swine Parvovirus Disease Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Swine Parvovirus Disease Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Swine Parvovirus Disease Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Swine Parvovirus Disease Vaccine Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Swine Parvovirus Disease Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Swine Parvovirus Disease Vaccine Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Swine Parvovirus Disease Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Swine Parvovirus Disease Vaccine Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Swine Parvovirus Disease Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Swine Parvovirus Disease Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Swine Parvovirus Disease Vaccine, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Swine Parvovirus Disease Vaccine, Product Type & Application
    Table 12. Global Key Manufacturers of Swine Parvovirus Disease Vaccine, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Swine Parvovirus Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Parvovirus Disease Vaccine as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Swine Parvovirus Disease Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Swine Parvovirus Disease Vaccine Sales by Region (2019-2024) & (K Units)
    Table 18. Global Swine Parvovirus Disease Vaccine Sales Market Share by Region (2019-2024)
    Table 19. Global Swine Parvovirus Disease Vaccine Sales by Region (2025-2030) & (K Units)
    Table 20. Global Swine Parvovirus Disease Vaccine Sales Market Share by Region (2025-2030)
    Table 21. Global Swine Parvovirus Disease Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Swine Parvovirus Disease Vaccine Revenue Market Share by Region (2019-2024)
    Table 23. Global Swine Parvovirus Disease Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Swine Parvovirus Disease Vaccine Revenue Market Share by Region (2025-2030)
    Table 25. North America Swine Parvovirus Disease Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Swine Parvovirus Disease Vaccine Sales by Country (2019-2024) & (K Units)
    Table 27. North America Swine Parvovirus Disease Vaccine Sales by Country (2025-2030) & (K Units)
    Table 28. North America Swine Parvovirus Disease Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Swine Parvovirus Disease Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Swine Parvovirus Disease Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Swine Parvovirus Disease Vaccine Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Swine Parvovirus Disease Vaccine Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Swine Parvovirus Disease Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Swine Parvovirus Disease Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Swine Parvovirus Disease Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Swine Parvovirus Disease Vaccine Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Swine Parvovirus Disease Vaccine Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Swine Parvovirus Disease Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Swine Parvovirus Disease Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Swine Parvovirus Disease Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Swine Parvovirus Disease Vaccine Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Swine Parvovirus Disease Vaccine Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Swine Parvovirus Disease Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Swine Parvovirus Disease Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Swine Parvovirus Disease Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Swine Parvovirus Disease Vaccine Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Swine Parvovirus Disease Vaccine Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Swine Parvovirus Disease Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Swine Parvovirus Disease Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Swine Parvovirus Disease Vaccine Sales (K Units) by Type (2019-2024)
    Table 51. Global Swine Parvovirus Disease Vaccine Sales (K Units) by Type (2025-2030)
    Table 52. Global Swine Parvovirus Disease Vaccine Sales Market Share by Type (2019-2024)
    Table 53. Global Swine Parvovirus Disease Vaccine Sales Market Share by Type (2025-2030)
    Table 54. Global Swine Parvovirus Disease Vaccine Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Swine Parvovirus Disease Vaccine Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Swine Parvovirus Disease Vaccine Revenue Market Share by Type (2019-2024)
    Table 57. Global Swine Parvovirus Disease Vaccine Revenue Market Share by Type (2025-2030)
    Table 58. Global Swine Parvovirus Disease Vaccine Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Swine Parvovirus Disease Vaccine Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Swine Parvovirus Disease Vaccine Sales (K Units) by Application (2019-2024)
    Table 61. Global Swine Parvovirus Disease Vaccine Sales (K Units) by Application (2025-2030)
    Table 62. Global Swine Parvovirus Disease Vaccine Sales Market Share by Application (2019-2024)
    Table 63. Global Swine Parvovirus Disease Vaccine Sales Market Share by Application (2025-2030)
    Table 64. Global Swine Parvovirus Disease Vaccine Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Swine Parvovirus Disease Vaccine Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Swine Parvovirus Disease Vaccine Revenue Market Share by Application (2019-2024)
    Table 67. Global Swine Parvovirus Disease Vaccine Revenue Market Share by Application (2025-2030)
    Table 68. Global Swine Parvovirus Disease Vaccine Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Swine Parvovirus Disease Vaccine Price (US$/Unit) by Application (2025-2030)
    Table 70. Merck Animal Health Corporation Information
    Table 71. Merck Animal Health Description and Business Overview
    Table 72. Merck Animal Health Swine Parvovirus Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Merck Animal Health Swine Parvovirus Disease Vaccine Product
    Table 74. Merck Animal Health Recent Developments/Updates
    Table 75. HIPRA Corporation Information
    Table 76. HIPRA Description and Business Overview
    Table 77. HIPRA Swine Parvovirus Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. HIPRA Swine Parvovirus Disease Vaccine Product
    Table 79. HIPRA Recent Developments/Updates
    Table 80. Zoetis Corporation Information
    Table 81. Zoetis Description and Business Overview
    Table 82. Zoetis Swine Parvovirus Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Zoetis Swine Parvovirus Disease Vaccine Product
    Table 84. Zoetis Recent Developments/Updates
    Table 85. Ceva Corporation Information
    Table 86. Ceva Description and Business Overview
    Table 87. Ceva Swine Parvovirus Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Ceva Swine Parvovirus Disease Vaccine Product
    Table 89. Ceva Recent Developments/Updates
    Table 90. Bioveta Corporation Information
    Table 91. Bioveta Description and Business Overview
    Table 92. Bioveta Swine Parvovirus Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Bioveta Swine Parvovirus Disease Vaccine Product
    Table 94. Bioveta Recent Developments/Updates
    Table 95. Boehringer Ingelheim Corporation Information
    Table 96. Boehringer Ingelheim Description and Business Overview
    Table 97. Boehringer Ingelheim Swine Parvovirus Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Boehringer Ingelheim Swine Parvovirus Disease Vaccine Product
    Table 99. Boehringer Ingelheim Recent Developments/Updates
    Table 100. Harbin Pharmaceutical Group Corporation Information
    Table 101. Harbin Pharmaceutical Group Description and Business Overview
    Table 102. Harbin Pharmaceutical Group Swine Parvovirus Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Harbin Pharmaceutical Group Swine Parvovirus Disease Vaccine Product
    Table 104. Harbin Pharmaceutical Group Recent Developments/Updates
    Table 105. Wuhan Keqian Biology Corporation Information
    Table 106. Wuhan Keqian Biology Description and Business Overview
    Table 107. Wuhan Keqian Biology Swine Parvovirus Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Wuhan Keqian Biology Swine Parvovirus Disease Vaccine Product
    Table 109. Wuhan Keqian Biology Recent Developments/Updates
    Table 110. DHN Corporation Information
    Table 111. DHN Description and Business Overview
    Table 112. DHN Swine Parvovirus Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. DHN Swine Parvovirus Disease Vaccine Product
    Table 114. DHN Recent Developments/Updates
    Table 115. China Animal Husbandy Industry Corporation Information
    Table 116. China Animal Husbandy Industry Description and Business Overview
    Table 117. China Animal Husbandy Industry Swine Parvovirus Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. China Animal Husbandy Industry Swine Parvovirus Disease Vaccine Product
    Table 119. China Animal Husbandy Industry Recent Developments/Updates
    Table 120. Qilu Animal Health Products Factorys Corporation Information
    Table 121. Qilu Animal Health Products Factorys Description and Business Overview
    Table 122. Qilu Animal Health Products Factorys Swine Parvovirus Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Qilu Animal Health Products Factorys Swine Parvovirus Disease Vaccine Product
    Table 124. Qilu Animal Health Products Factorys Recent Developments/Updates
    Table 125. Shandong HuaHong Biological Engineering Corporation Information
    Table 126. Shandong HuaHong Biological Engineering Description and Business Overview
    Table 127. Shandong HuaHong Biological Engineering Swine Parvovirus Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Shandong HuaHong Biological Engineering Swine Parvovirus Disease Vaccine Product
    Table 129. Shandong HuaHong Biological Engineering Recent Developments/Updates
    Table 130. Shanghai Hile Biological Corporation Information
    Table 131. Shanghai Hile Biological Description and Business Overview
    Table 132. Shanghai Hile Biological Swine Parvovirus Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. Shanghai Hile Biological Swine Parvovirus Disease Vaccine Product
    Table 134. Shanghai Hile Biological Recent Developments/Updates
    Table 135. Liaoning Yikang Biological Corporation Information
    Table 136. Liaoning Yikang Biological Description and Business Overview
    Table 137. Liaoning Yikang Biological Swine Parvovirus Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. Liaoning Yikang Biological Swine Parvovirus Disease Vaccine Product
    Table 139. Liaoning Yikang Biological Recent Developments/Updates
    Table 140. Jilin Zhengye Biological Product Corporation Information
    Table 141. Jilin Zhengye Biological Product Description and Business Overview
    Table 142. Jilin Zhengye Biological Product Swine Parvovirus Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 143. Jilin Zhengye Biological Product Swine Parvovirus Disease Vaccine Product
    Table 144. Jilin Zhengye Biological Product Recent Developments/Updates
    Table 145. Key Raw Materials Lists
    Table 146. Raw Materials Key Suppliers Lists
    Table 147. Swine Parvovirus Disease Vaccine Distributors List
    Table 148. Swine Parvovirus Disease Vaccine Customers List
    Table 149. Swine Parvovirus Disease Vaccine Market Trends
    Table 150. Swine Parvovirus Disease Vaccine Market Drivers
    Table 151. Swine Parvovirus Disease Vaccine Market Challenges
    Table 152. Swine Parvovirus Disease Vaccine Market Restraints
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Swine Parvovirus Disease Vaccine
    Figure 2. Global Swine Parvovirus Disease Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Swine Parvovirus Disease Vaccine Market Share by Type in 2023 & 2030
    Figure 4. <107.0 TCID50/mL Product Picture
    Figure 5. ≥107.0 TCID50/mL Product Picture
    Figure 6. Global Swine Parvovirus Disease Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Swine Parvovirus Disease Vaccine Market Share by Application in 2023 & 2030
    Figure 8. Sows
    Figure 9. Boars
    Figure 10. Global Swine Parvovirus Disease Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Swine Parvovirus Disease Vaccine Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Swine Parvovirus Disease Vaccine Sales (2019-2030) & (K Units)
    Figure 13. Global Swine Parvovirus Disease Vaccine Average Price (US$/Unit) & (2019-2030)
    Figure 14. Swine Parvovirus Disease Vaccine Report Years Considered
    Figure 15. Swine Parvovirus Disease Vaccine Sales Share by Manufacturers in 2023
    Figure 16. Global Swine Parvovirus Disease Vaccine Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Swine Parvovirus Disease Vaccine Players: Market Share by Revenue in 2023
    Figure 18. Swine Parvovirus Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Swine Parvovirus Disease Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Swine Parvovirus Disease Vaccine Sales Market Share by Country (2019-2030)
    Figure 21. North America Swine Parvovirus Disease Vaccine Revenue Market Share by Country (2019-2030)
    Figure 22. United States Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Swine Parvovirus Disease Vaccine Sales Market Share by Country (2019-2030)
    Figure 25. Europe Swine Parvovirus Disease Vaccine Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. U.K. Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Swine Parvovirus Disease Vaccine Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Swine Parvovirus Disease Vaccine Revenue Market Share by Region (2019-2030)
    Figure 33. China Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. China Taiwan Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Southeast Asia Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Latin America Swine Parvovirus Disease Vaccine Sales Market Share by Country (2019-2030)
    Figure 41. Latin America Swine Parvovirus Disease Vaccine Revenue Market Share by Country (2019-2030)
    Figure 42. Mexico Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Brazil Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Argentina Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Swine Parvovirus Disease Vaccine Sales Market Share by Country (2019-2030)
    Figure 46. Middle East & Africa Swine Parvovirus Disease Vaccine Revenue Market Share by Country (2019-2030)
    Figure 47. Turkey Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Saudi Arabia Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. UAE Swine Parvovirus Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Global Sales Market Share of Swine Parvovirus Disease Vaccine by Type (2019-2030)
    Figure 51. Global Revenue Market Share of Swine Parvovirus Disease Vaccine by Type (2019-2030)
    Figure 52. Global Swine Parvovirus Disease Vaccine Price (US$/Unit) by Type (2019-2030)
    Figure 53. Global Sales Market Share of Swine Parvovirus Disease Vaccine by Application (2019-2030)
    Figure 54. Global Revenue Market Share of Swine Parvovirus Disease Vaccine by Application (2019-2030)
    Figure 55. Global Swine Parvovirus Disease Vaccine Price (US$/Unit) by Application (2019-2030)
    Figure 56. Swine Parvovirus Disease Vaccine Value Chain
    Figure 57. Swine Parvovirus Disease Vaccine Production Process
    Figure 58. Channels of Distribution (Direct Vs Distribution)
    Figure 59. Distributors Profiles
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS